ArticleAntimicrobial agents and chemotherapy2018

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.

Jérémie Piton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.